glp-1 bad for you Your guide to side effects GLP-1 Agonist: The Good, the

See if You Qualify The Ozempic Lawsuit is an active lawsuit See If You Qualify Ozempic and Gastroparesis Overview Litigation is pending against Novo Nordisk, the manufacturer of Ozempic, for allegedly not properly warning about the potentially severe gastrointestinal side effects related to its GLP-1 drugs

NHS England is developing more specific guidance on clinical prioritisation in early 2025 in preparation for implementing this programme

These effects occur due to the delayed gastric emptying caused by GLP-1 agonists

Based on the phase 2 and phase 3 trial protocols: Weeks 1-4: 1 mg once weekly Weeks 5-8: 2 mg once weekly Weeks 9-12: 4 mg once weekly Weeks 13-16: 8 mg once weekly Weeks 17 onward: 12 mg once weekly (maximum dose) The starting dose of retatrutide is deliberately low because the triple-agonist mechanism produces more intense initial side effects than single-pathway compounds

They did find a higher rate of RGC (OR 5.56, 95% CI 3.35 to 9.23) and rates of abandonment of procedures (OR 5.13, 95% CI 3.01 to 8.75)

This is a conversation to have with your prescribing provider, as it involves using the medication in an off-label manner